tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Xenetic reports Q2 EPS (45c)  vs. (83c) last year
PremiumThe FlyXenetic reports Q2 EPS (45c) vs. (83c) last year
3M ago
Xenetic Biosciences Reports Improved Financial Performance
Premium
Company Announcements
Xenetic Biosciences Reports Improved Financial Performance
3M ago
Is XBIO a Buy, Before Earnings?
Premium
Pre-Earnings
Is XBIO a Buy, Before Earnings?
3M ago
Xenetic reports Q1 EPS (59c)  vs. (78c) last year
PremiumThe FlyXenetic reports Q1 EPS (59c) vs. (78c) last year
6M ago
Xenetic partner PeriNess enters clinical study agreement for XBIO-015
Premium
The Fly
Xenetic partner PeriNess enters clinical study agreement for XBIO-015
7M ago
Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
Premium
The Fly
Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
7M ago
Xenetic presents preclinical data on DNase I with CAR T cells in murine model
PremiumThe FlyXenetic presents preclinical data on DNase I with CAR T cells in murine model
11M ago
Xenetic reports Q3 EPS (28c) vs. (69c) last year
Premium
The Fly
Xenetic reports Q3 EPS (28c) vs. (69c) last year
12M ago
Xenetic presents preclinical data on DNase platform technology
Premium
The Fly
Xenetic presents preclinical data on DNase platform technology
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100